Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Drugs in Context is Scopus-indexed (Q1, CiteScore 5), WoS ESCI, DOAJ. Published by Bioexcel Publishing LTD.
Checked against the index lists dated .
ISSN 1740-4398Verify ISSN ↗1745-1981Verify ISSN ↗
Publisher: Bioexcel Publishing LTD
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 94 / 669 | 86th | Q1 |
| Pharmacology | 140 / 328 | 57th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present (also 2006–2008), best quartile Q1, CiteScore 5.
Drugs in Context is Q1 in Medicine (all) (rank 94 of 669) and Q2 in Pharmacology (rank 140 of 328), by CiteScore 2025.
Drugs in Context is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5, which places it in quartile Q1 at the 86th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.659, quartile Q2, with an H-index of 44.
The publisher lists an article processing charge of about US$1,901 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Drugs in Context is published by Bioexcel Publishing LTD. Its print ISSN is 1740-4398 and its online ISSN is 1745-1981.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Drugs in Context has an h-index of 53 and a 2-year mean of 2.37 citations per paper (OpenAlex). Its Scopus CiteScore is 5, quartile Q1. On 2-year citations it ranks #118 of 646 Scopus journals in Medicine (all).
Drugs in Context published 49 papers in 2025; its busiest recent year was 2020 with 75. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2024–2026), authors are most often from Italy (40%), Spain (12.9%) and Greece (6.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.